Don Schmechel

A Double-Blind, Placebo-Controlled, Ascending-Dose, Randomized Study to Evaluate the Safety, Tolerability and Effects on Cognition of AL-108 after 12 Weeks of Intranasal Administration in Subjects with Mild Cognitive Impairment

Bruce H. Morimoto, Don Schmechel, Joe Hirman et al. · Dementia and Geriatric Cognitive Disorders · 2013 · 111 citations

Cystatin C Mutation in an Elderly Man With Sporadic Amyloid Angiopathy and Intracerebral Hemorrhage

Carmelo Graffagnino, Michael H. Herbstreith, Don Schmechel et al. · Stroke · 1995 · 51 citations

Genomic convergence to identify candidate genes for Parkinson disease: SAGE analysis of the substantia nigra

Maher Noureddine, Yi‐Ju Li, Joelle M. van der Walt et al. · Movement Disorders · 2005 · 51 citations

Proxies and Consent Discussions for Dementia Research

Jeremy Sugarman, Debra Roter, Carole Cain et al. · Journal of the American Geriatrics Society · 2007 · 35 citations

Effect of heterogeneity on the chromosome 10 risk in late-onset Alzheimer disease

Xueying Liang, Eden R. Martin, Nathalie Schnetz‐Boutaud et al. · Human Mutation · 2007 · 14 citations